Gilead Stock Jumps After Its Weight-Loss Drug Emerges From Under The Radar

Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.

Related Keywords

United States ,American ,Eli Lilly ,Novo Wegovy ,Lilly Zepbound ,Gilead Sciences ,Goldman Sachs ,American Diabetes Association ,Wall Street ,Umer Raffat ,Structure Therapeutics ,Huge Weight Loss Drugs ,Novo Nordisk ,